Details for New Drug Application (NDA): 213181
✉ Email this page to a colleague
The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 213181
| Tradename: | DIVALPROEX SODIUM |
| Applicant: | Ajanta Pharma Ltd |
| Ingredient: | divalproex sodium |
| Patents: | 0 |
Pharmacology for NDA: 213181
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 213181
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIVALPROEX SODIUM | divalproex sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 213181 | ANDA | Ajanta Pharma USA Inc. | 27241-115 | 27241-115-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (27241-115-01) |
| DIVALPROEX SODIUM | divalproex sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 213181 | ANDA | Ajanta Pharma USA Inc. | 27241-115 | 27241-115-05 | 500 CAPSULE, COATED PELLETS in 1 BOTTLE (27241-115-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 125MG VALPROIC ACID | ||||
| Approval Date: | Mar 2, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
